LBA
BLU

Letko, Brosseau & Associates’s BELLUS Health Inc. BLU Stock Holding History

Letko, Brosseau & Associates’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,500
Closed -$155K – 97
2023
Q1 		$155K Buy
21,500
+5,500
+34% +$42.7K ﹤0.01% 86
2022
Q4 		$132K Buy
+16,000
New +$149K ﹤0.01% 95

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Letko, Brosseau & Associates's BLU Position: Q2 2023 in Review

Letko, Brosseau & Associates sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 21,500 shares — an estimated $155K sold.

Letko, Brosseau & Associates first reported a position in BLU in Q4 2022 and held it in 2 quarters. The position peaked at $155K in Q1 2023. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Letko, Brosseau & Associates reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 21,500 BELLUS Health Inc. shares in Q2 2023, an estimated $155K.
  • Letko, Brosseau & Associates first reported a position in BELLUS Health Inc. in Q4 2022 and held it in 2 quarters.
  • Letko, Brosseau & Associates's BELLUS Health Inc. position peaked at $155K in Q1 2023.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2023, filed 10 Aug 2023.